Clotting factor deficiencies may also be due to reduced synthesis for hepatic disease, increased clearance in enlarged spleen, or accelerated consumption in a state of low-grade intravascular coagulation and fibrinolysis, supported by IL-1α, TNF-α, and IL-6. The gene discussed is IL1A; the disease is liver disorder.